Contract facts
FederalFIPPS PHASE 2 DME WORK is a federal award for Fda Office Of Acq Grant Svcs held by Estars Enterprise, LLC. Estimated value $4.5M ($1.8M obligated). Current period of performance ends May 13, 2022. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.
Recompete timing
PublicCurrent PoP ended May 13, 2022 (1561 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40120F80398?
75F40120F80398 (FIPPS PHASE 2 DME WORK) is a Fda Office Of Acq Grant Svcs award with a potential value of $4.5M, currently held by Estars Enterprise, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40120F80398?
Fda Office Of Acq Grant Svcs awarded 75F40120F80398 to Estars Enterprise, LLC (potential $4.5M).
Who is the incumbent on 75F40120F80398?
Estars Enterprise, LLC is the incumbent. The current period of performance ends May 13, 2022.
When does Estars Enterprise, LLC’s 75F40120F80398 come up for recompete?
SCOUT tracks a period-of-performance end of May 13, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.